SCHEMBL12424142

SCHEMBL12424142

OC(c1cccnc1)c1c(Cc2ccc(Cl)cc2Cl)noc1-c1ccsc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 1/20 0.36
PPARA Q07869 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
RORC P51449 1/20 0.34
CYP3A4 P08684 4/20 0.34
CYP2C9 P11712 3/20 0.34
CYP2C19 P33261 2/20 0.34
CYP2A6 P11509 1/20 0.34
CYP2B6 P20813 1/20 0.34
PDE10A Q9Y233 1/20 0.33
CYP1A2 P05177 1/20 0.33
GAA P10253 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2196888 0.85 TSHR (0.40) L3MBTL1LMNASMN1; SMN2TSHRMAPK1
SCHEMBL2196040 0.84 KCNA5 (0.39) L3MBTL1LMNASMN1; SMN2TSHRMAPK1
SCHEMBL2199012 0.83 NPC1 (0.39) L3MBTL1LMNASMN1; SMN2TSHRMAPK1
SCHEMBL2195122 0.80 PPARA (0.39) L3MBTL1LMNASMN1; SMN2TSHRPPARA
SCHEMBL2198580 0.79 GAA (0.39) L3MBTL1LMNASMN1; SMN2TSHRMAPK1
SCHEMBL2197507 0.78 PPARA (0.39) L3MBTL1LMNASMN1; SMN2TSHRPPARA
SCHEMBL2201038 0.77 KCNA5 (0.44) L3MBTL1LMNASMN1; SMN2TSHRPPARA
SCHEMBL2195105 0.77 L3MBTL1 (0.43) L3MBTL1LMNASMN1; SMN2TSHRPPARA
SCHEMBL2198000 0.76 CYP3A4 (0.45) L3MBTL1LMNASMN1; SMN2MAPK1RAB9A
SCHEMBL2199157 0.74 SMN1; SMN2 (0.43) L3MBTL1LMNASMN1; SMN2TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977341-B2 For crops; 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethylsilylisoxazole for example SYNGENTA LIMITED (GB) 2011-07-12 US disclosed
US-7977341-B2 For crops; 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethylsilylisoxazole for example SYNGENTA LIMITED (GB) 2011-07-12 US disclosed
US-20080096843-A1 Substituted Isoxazoles as Fungicides SYNGENTA LIMITED (GB) 2008-04-24 US disclosed
US-20080096843-A1 Substituted Isoxazoles as Fungicides SYNGENTA LIMITED (GB) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096843-A1 Substituted Isoxazoles as Fungicides CYP4X1, CYP51A1, CYP3A7 L3MBTL1 4110/4885LMNA 3361/4885SMN1; SMN2 2387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.